Circulating CD34+ cells: An adverse prognostic factor in the myelodysplastic syndromes
Author:
Publisher
Wiley
Subject
Hematology
Reference23 articles.
1. Proposals for the classification of the myelodysplastic syndromes
2. 5 Myelodysplastic syndromes
3. Myelodysplastic syndromes: a scoring system with prognostic significance
4. Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Higher Level of Peripheral Blood CD34 Positive Cells Presented with Unfavorable Prognosis in Intermediate-Low Risk Acute Promyelocytic Leukemia;Indian Journal of Hematology and Blood Transfusion;2019-12-17
2. Pretreatment CD34+/CD38– Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2019-08
3. Characterization of CD34 + hematopoietic cells in systemic mastocytosis: Potential role in disease dissemination;Allergy;2018-02-13
4. The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors;Hematology;2016-03-31
5. Functional evaluation of circulating hematopoietic progenitors in Noonan syndrome;Oncology Reports;2013-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3